IDStewardship

  • Home
  • Articles
  • LEARN ANTIBIOTICS
  • Study Guide
  • Resources
  • Q&A
  • #ASPchat
  • Contributors
  • About

Posaconazole

[Posaconazole photo]

KEY POINTS

  • Posaconazole (Noxafil) is a triazole antifungal that works by inhibiting the synthesis of ergosterol
    • Ergosterol is the primary sterol in the fungal cell wall
  • Has activity against fungi such as Candida species, Aspergillus species, and zygomycetes
  • FDA-approved for:
    • Prophylaxis versus invasive aspergillosis in severely immunocompromised patients
    • Oropharyngeal candidiasis
    • Prophylaxis versus invasive candidiasis in severely immunocompromised patients
  • Available oral and injectable
    • The delayed-release tablets and oral suspensions are not interchangeable directly, dosage must be adjusted
  • Dose and frequency vary depending on the indication
    • Usually dosed in either 200mg, 300mg, or 400mg per dose
    • The IV formulation is generally avoided for creatinine clearance below 50 mL/min, because the vehicle the drug is provided in can accumulate and cause toxicity
  • Drug levels are frequently monitored to ensure adequate absorption
    • The delayed-release tablet should be taken with food
    • The oral suspension should be given within 20 minutes of a full meal
  • Beware drug-drug interactions, posaconazole use is contraindicated with many other drugs
  • Some adverse reactions to beware include: hypokalemia, diarrhea, nausea, headache, fever, prolonged QT interval, and liver toxicity

RESOURCES

  • Posaconazole Package Insert (oral solution)
  • Posaconazole Package Insert (delayed-release tablet)
  • Posaconazole Package Insert (intravenous)
  • 2016 IDSA Aspergillus Guideline
  • 2016 IDSA Candidiasis Guideline
  • 2014 Therapeutic Drug Monitoring of Antifungal Agents – Guidelines from the British Society for Medical Microbiology
  • 2016 Review of Therapeutic Drug Monitoring of Posaconazole
  • 2006 Pharmacology of Systemic Antifungal Agents

Free Antibiotic Cheat Sheet

Study Guide

  • Pharmacotherapy Study Guide
  • Acyclovir
  • Albendazole
  • Amikacin
  • Aminoglycosides
  • Amphotericin B
  • Amoxicillin
  • Amoxicillin-Clavulanic Acid
  • Ampicillin
  • Ampicillin-sulbactam
  • Anidulafungin
  • Artesunate
  • Atovaquone
  • Azithromycin
  • Aztreonam
  • Bacitracin
  • Baloxavir marboxyl (Xofluza)
  • Bamlanivimab
  • Baricitinib
  • Bezlotoxumab
  • Casirivimab and Imdevimab
  • Caspofungin
  • Cefazolin
  • Cefepime
  • Cefiderocol
  • Ceftaroline
  • Ceftazidime
  • Ceftazidime-avibactam
  • Ceftolozane-Tazobactam
  • Ceftriaxone
  • Cefoxitin
  • Cephalexin
  • Ciprofloxacin
  • Clarithromycin
  • Clindamycin
  • Colistin (colistimethate)
  • Cycloserine
  • Dalbavancin
  • Daptomycin
  • Delafloxacin
  • Dicloxacillin
  • Doripenem
  • Doxycycline
  • Elbasvir/ grazoprevir
  • Eravacycline
  • Ertapenem
  • Erythromycin
  • Famciclovir
  • Fidaxomicin
  • Fluconazole
  • Flucytosine
  • Foscarnet
  • Fosfomycin
  • Ganciclovir
  • Gentamicin
  • Glecaprevir/ Pibrentasvir
  • Imipenem-cilastatin
  • Imipenem-cilastatin-relebactam
  • Isavuconazole
  • Itraconazole
  • Ivermectin
  • Ledipasvir/sofosbuvir
  • Lefamulin
  • Letermovir
  • Levofloxacin
  • Linezolid
  • Meropenem
  • Meropenem-vaborbactam
  • Metronidazole
  • Methenamine
  • Micafungin
  • Minocycline
  • Moxifloxacin
  • Nafcillin
  • Nitrofurantoin
  • Omadacycline
  • Oritavancin
  • Oseltamivir
  • Oxacillin
  • Penicillin
  • Penicillin Skin Test
  • Phenazopyridine
  • Piperacillin-tazobactam
  • Plazomicin
  • Polymyxin B
  • Posaconazole
  • Quinupristin-dalfopristin
  • Remdesivir
  • Ribavirin
  • Rifabutin
  • Rifampin
  • Secnidazole
  • Sofosbuvir/ velpatasvir/ voxilaprevir
  • Sulfadiazine
  • Sulfamethoxazole-Trimethoprim (Bactrim)
  • Tedizolid
  • Telavancin
  • Tigecycline
  • Tobramycin
  • Tocilizumab
  • Valacyclovir
  • Valganciclovir
  • Vancomycin
  • Voriconazole
  • Zidovudine
  • Zoster vaccine recombinant, adjuvanted (Shingrix)

Recent

  • How Ibrexafungerp Got Its Name
  • Five Challenges With Creating And Managing Institutional Guidelines For Infectious Diseases
  • Three Resources Pharmacists Can Use To Improve Their Antimicrobial Stewardship Research Skills
  • A Comparison Of Bamlanivimab Versus Bamlanivimab-Etesevimab
  • Top 10 Most Viewed IDstewardship Articles During the COVID-19 Pandemic

Search

Copyright 2016-2020 By Charlie Rose, LLC © · IDStewardship.com · Copyright · Privacy Policy · Terms · Contact